AN2 Therapeutics, Inc 10-K for FY2022
AN2 Therapeutics, Inc. (ANTX)
10-K
2023-03-29
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 10-K
AN2 Therapeutics, Inc filed this 10-K on March 29, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $40.96M
- compared with a net loss of $21.54M a year earlier
- Diluted EPS
- -$2.79
- compared with -$10.64 a year earlier